Evolving role of 18F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma

被引：4

作者：

Dam, Hung Q.

Manzone, Timothy M.

Sagar, Vidya V.

机构：

[1] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Dept Nucl Med, Newark, DE 19718 USA

[2] Wilmington Vet Affairs Med Ctr, Dept Nucl Med, Wilmington, DE 19805 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2006年 / 15卷 / 04期

关键词：

D O I：

10.1016/j.soc.2006.07.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) and PET/CT imaging with F-18-fluorodeoxyglucose are metabolic imaging modalities that depict tissues based on their level of glucose uptake. PET provides useful information in the primary staging of disease. PET performance in detecting locoregional nodal metastases is limited; however, it is the most accurate single noninvasive modality for detecting distant metastases. It is the imaging modality of choice for whole-body scanning in high-risk patients or patients who have clinically suspected recurrence, and is particularly helpful in determining which patients are the best candidates for surgical cure.

引用

页码：733 / +

页数：18

共 68 条

[1] Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer [J].